Furthermore, the severity of hepatic fibrosis was positively correlated with the level of SRD5A2 expression, suggesting that an elevated level of SRD5A2 expression may promote the development of fibrosis by reducing MMP-2 activity and impairing the degradation of extrahepatic matrix proteins. The gene discussed is SRD5A2; the disease is Hepatic fibrosis.